Shingles (Herpes Zoster): Prevention
As of March 2018, an adjuvanted subunit total vaccine (containing glycoprotein E of the pathogen) has been approved for the prevention of herpes zoster (HZ) and postherpetic neuralgia (PHN) in persons 50 years of age and older. This has a high protective effect even in older age groups and, in addition to good safety, has … Shingles (Herpes Zoster): Prevention